UA78672C2 - Method for preparation and use of conductive medicinal substance (variants) - Google Patents
Method for preparation and use of conductive medicinal substance (variants) Download PDFInfo
- Publication number
- UA78672C2 UA78672C2 UA2001042681A UA2001042681A UA78672C2 UA 78672 C2 UA78672 C2 UA 78672C2 UA 2001042681 A UA2001042681 A UA 2001042681A UA 2001042681 A UA2001042681 A UA 2001042681A UA 78672 C2 UA78672 C2 UA 78672C2
- Authority
- UA
- Ukraine
- Prior art keywords
- conductive substance
- electrically conductive
- electrodes
- substance
- patient
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 238000000034 method Methods 0.000 title abstract description 28
- 239000012907 medicinal substance Substances 0.000 title 1
- 239000000126 substance Substances 0.000 claims abstract description 207
- 241001465754 Metazoa Species 0.000 claims abstract description 12
- 238000002347 injection Methods 0.000 claims abstract description 11
- 239000007924 injection Substances 0.000 claims abstract description 11
- 230000002685 pulmonary effect Effects 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 claims description 27
- 238000011282 treatment Methods 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 230000004913 activation Effects 0.000 claims description 16
- 229940079593 drug Drugs 0.000 claims description 15
- 239000003990 capacitor Substances 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 11
- 239000000725 suspension Substances 0.000 claims description 10
- 230000009471 action Effects 0.000 claims description 9
- 210000004204 blood vessel Anatomy 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 4
- 206010014561 Emphysema Diseases 0.000 claims description 3
- 230000004087 circulation Effects 0.000 claims description 3
- 230000012010 growth Effects 0.000 claims description 3
- 238000001990 intravenous administration Methods 0.000 claims description 3
- 238000006073 displacement reaction Methods 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 208000005069 pulmonary fibrosis Diseases 0.000 claims description 2
- 210000001835 viscera Anatomy 0.000 claims description 2
- 230000008030 elimination Effects 0.000 claims 2
- 238000003379 elimination reaction Methods 0.000 claims 2
- 238000001914 filtration Methods 0.000 claims 2
- 238000010253 intravenous injection Methods 0.000 claims 2
- 239000004020 conductor Substances 0.000 claims 1
- 238000005728 strengthening Methods 0.000 claims 1
- 208000011117 substance-related disease Diseases 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 abstract description 7
- 230000008859 change Effects 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 230000000704 physical effect Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 30
- 210000001519 tissue Anatomy 0.000 description 28
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
- 238000001994 activation Methods 0.000 description 18
- 239000011780 sodium chloride Substances 0.000 description 10
- 230000010355 oscillation Effects 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 210000001367 artery Anatomy 0.000 description 6
- 238000005868 electrolysis reaction Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 230000002503 metabolic effect Effects 0.000 description 5
- 239000008399 tap water Substances 0.000 description 5
- 235000020679 tap water Nutrition 0.000 description 5
- 230000006378 damage Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000001827 electrotherapy Methods 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000007792 addition Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000007665 sagging Methods 0.000 description 3
- 230000003313 weakening effect Effects 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000809 air pollutant Substances 0.000 description 1
- 231100001243 air pollutant Toxicity 0.000 description 1
- 210000004712 air sac Anatomy 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000036782 biological activation Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000004870 electrical engineering Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000007770 graphite material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 238000000968 medical method and process Methods 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000008986 metabolic interaction Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 208000030247 mild fever Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000012811 non-conductive material Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000010943 off-gassing Methods 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- -1 tissue products Chemical class 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Electrotherapy Devices (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/289,409 US6488032B1 (en) | 1997-05-29 | 1999-04-09 | Method of providing cosmetic/medical therapy |
| PCT/US1999/028749 WO2000061221A1 (en) | 1999-04-09 | 1999-12-02 | Method of providing cosmetic/medical therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA78672C2 true UA78672C2 (en) | 2007-04-25 |
Family
ID=23111412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2001042681A UA78672C2 (en) | 1999-04-09 | 1999-02-12 | Method for preparation and use of conductive medicinal substance (variants) |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6488032B1 (pt) |
| EP (1) | EP1169082A1 (pt) |
| JP (1) | JP2002541222A (pt) |
| KR (1) | KR100670096B1 (pt) |
| CN (1) | CN1209172C (pt) |
| AU (1) | AU777730B2 (pt) |
| BR (1) | BR9914945A (pt) |
| CA (1) | CA2356128A1 (pt) |
| HK (2) | HK1043326A1 (pt) |
| IL (2) | IL142581A0 (pt) |
| NO (1) | NO20014812D0 (pt) |
| NZ (1) | NZ511238A (pt) |
| PL (1) | PL198794B1 (pt) |
| RU (1) | RU2244573C2 (pt) |
| TR (1) | TR200102816T2 (pt) |
| UA (1) | UA78672C2 (pt) |
| WO (1) | WO2000061221A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6920884B2 (en) * | 1997-05-29 | 2005-07-26 | Kevin Orton | Method of providing cosmetic/medical therapy |
| JP2003525661A (ja) * | 1999-09-21 | 2003-09-02 | ケヴィン オートン、 | 注射可能な物質を電気的に処理する装置 |
| AUPS019802A0 (en) * | 2002-01-31 | 2002-02-21 | Chemstop Pty Ltd | Nutrient formulation |
| US20030181845A1 (en) * | 2002-03-21 | 2003-09-25 | Orton Kevin R. | Preparation and delivery of healthcare services utilizing electrolytic medicament |
| DE10321654A1 (de) * | 2003-05-14 | 2004-12-09 | Leeser, Rolf, Dr.med. | Verfahren zum Abtöten von Mikroorganismen |
| JP4970069B2 (ja) * | 2007-01-30 | 2012-07-04 | 株式会社ニデック | 視覚再生補助装置 |
| EP2968928A1 (en) * | 2013-03-15 | 2016-01-20 | Nes Health, Ltd. | Pulse polarity switching for improved human body stimulation and healing |
| RU2678979C2 (ru) * | 2016-05-17 | 2019-02-05 | Олег Ильич Эпштейн | Средство для использования в гомеопатической технологии |
| RU2684284C1 (ru) * | 2018-01-30 | 2019-04-05 | Общество С Ограниченной Ответственностью "Научно-Производственная Фирма "Материа Медика Холдинг" | Способ терапевтического лечения острого нарушения мозгового кровообращения - инсульта по ишемическому типу в бассейне сонных артерий |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US408607A (en) | 1889-08-06 | Electric drinking-vessel | ||
| US397474A (en) | 1889-02-05 | Therapeutical electrode | ||
| US882378A (en) | 1907-01-23 | 1908-03-17 | Emanuel Friendlich | Drinking vessel. |
| US1108686A (en) | 1912-08-03 | 1914-08-25 | Harry Bonis | Electrotherapeutic fluid electrode. |
| US3163166A (en) | 1961-04-28 | 1964-12-29 | Colgate Palmolive Co | Iontophoresis apparatus |
| US3794022A (en) | 1972-06-30 | 1974-02-26 | E Nawracaj | Dual oscillator, variable pulse duration electrotherapeutic device |
| US4305390A (en) | 1975-11-28 | 1981-12-15 | Massachusetts Institute Of Technology | Method for generating oxygen in an excited electronic state and inactivation of microorganisms |
| US4147775A (en) | 1976-10-06 | 1979-04-03 | Schwartz Stephen H | Antiseptic composition |
| US4180079A (en) | 1978-03-16 | 1979-12-25 | Wing Thomas W | Electroacupuncture instrument |
| US4446870A (en) | 1978-03-16 | 1984-05-08 | Wing Thomas W | Electrical treatment method |
| US4474748A (en) | 1979-09-26 | 1984-10-02 | Johnson & Johnson | Medicaments potentiated with phenyl alkanols |
| IT1132508B (it) | 1980-07-04 | 1986-07-02 | Franco Donadelli | Metodo per l'incremento dei processi metabolici degli epitelli mediante applicazione biochimica d'un campo elettrico |
| HU185691B (en) | 1982-02-09 | 1985-03-28 | Richter Gedeon Vegyeszet | Process for preparing a new analgetic pharmaceutical composition |
| US4572194A (en) | 1982-10-05 | 1986-02-25 | Head Edwin L | Device for therapy of the human or animal body |
| US4540403A (en) | 1984-07-02 | 1985-09-10 | Alza Corporation | Parenteral dispensing system with programmable drug administration |
| US4822339A (en) | 1984-12-06 | 1989-04-18 | Controlled Release Technologies, Inc. | Therapeutic agent delivery system and method |
| IT206759Z2 (it) | 1985-07-08 | 1987-10-01 | Indiba Sa | Disposotivo elettronico per la terapia cosmetica a medica. |
| JP2810665B2 (ja) | 1987-06-15 | 1998-10-15 | 松下電工株式会社 | 血行促進装置 |
| IT1221615B (it) | 1987-10-20 | 1990-07-12 | Franco Bernardini | Stimolatore portatile per elettroanalgesia ad effetto transcutaneo |
| WO1990001957A1 (en) | 1988-08-29 | 1990-03-08 | Moisey Dobruskin | Medicinal drug, method of treatment of human diseases therewith, and method and device for producing and preserving thereof |
| US4980038A (en) | 1988-10-17 | 1990-12-25 | Shizuho Watanabe | Cosmetic and method for production thereof |
| EP0377057A1 (en) | 1988-12-30 | 1990-07-11 | Leandro Bernardini | Hand-operated electromedical device for analgesic skin treatments |
| CS275292B2 (en) | 1989-02-22 | 1992-02-19 | Cvut Fakulta Elektrotechnick | Private rehabilitation apparatus with ion transcutaneous acceleration |
| US5012816A (en) | 1989-08-31 | 1991-05-07 | Gabor Lederer | Electronic acupuncture device |
| US5188738A (en) | 1990-08-06 | 1993-02-23 | Steven Kaali | Alternating current supplied electrically conductive method and system for treatment of blood and/or other body fluids and/or synthetic fluids with electric forces |
| US5350415A (en) | 1993-03-08 | 1994-09-27 | Jozef Cywinski | Device for trophic stimulation of muscles |
| IES58223B2 (en) | 1993-03-22 | 1993-08-11 | Maitreya Corp Ltd | A homeopathic medicine |
| ITPD940149A1 (it) | 1994-08-30 | 1996-03-01 | Silvano Marcolongo | Idros-placca elettrolitica generatrice di ioni attivi. |
| US5885241A (en) | 1997-05-29 | 1999-03-23 | Orton; Kevin R. | Treatment with an electrically-activated substance |
| US9853876B1 (en) * | 2014-06-13 | 2017-12-26 | Narus, Inc. | Mobile application identification in network traffic via a search engine approach |
-
1999
- 1999-02-12 UA UA2001042681A patent/UA78672C2/uk unknown
- 1999-04-09 US US09/289,409 patent/US6488032B1/en not_active Expired - Fee Related
- 1999-12-02 EP EP99965120A patent/EP1169082A1/en not_active Ceased
- 1999-12-02 RU RU2001110081/14A patent/RU2244573C2/ru not_active IP Right Cessation
- 1999-12-02 KR KR1020017012854A patent/KR100670096B1/ko not_active IP Right Cessation
- 1999-12-02 AU AU31103/00A patent/AU777730B2/en not_active Ceased
- 1999-12-02 WO PCT/US1999/028749 patent/WO2000061221A1/en active IP Right Grant
- 1999-12-02 BR BR9914945-1A patent/BR9914945A/pt not_active Application Discontinuation
- 1999-12-02 IL IL14258199A patent/IL142581A0/xx unknown
- 1999-12-02 PL PL350850A patent/PL198794B1/pl unknown
- 1999-12-02 JP JP2000610552A patent/JP2002541222A/ja active Pending
- 1999-12-02 TR TR2001/02816T patent/TR200102816T2/xx unknown
- 1999-12-02 CA CA002356128A patent/CA2356128A1/en not_active Abandoned
- 1999-12-02 CN CNB998150703A patent/CN1209172C/zh not_active Expired - Fee Related
- 1999-12-02 NZ NZ511238A patent/NZ511238A/en not_active IP Right Cessation
-
2001
- 2001-04-13 IL IL142581A patent/IL142581A/en not_active IP Right Cessation
- 2001-10-03 NO NO20014812A patent/NO20014812D0/no not_active Application Discontinuation
-
2002
- 2002-07-04 HK HK02105023.8A patent/HK1043326A1/zh unknown
- 2002-07-09 HK HK02105111.1A patent/HK1045270A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2356128A1 (en) | 2000-10-19 |
| BR9914945A (pt) | 2001-10-30 |
| NZ511238A (en) | 2003-12-19 |
| AU777730B2 (en) | 2004-10-28 |
| US6488032B1 (en) | 2002-12-03 |
| WO2000061221A1 (en) | 2000-10-19 |
| KR100670096B1 (ko) | 2007-01-17 |
| NO20014812L (no) | 2001-10-03 |
| PL198794B1 (pl) | 2008-07-31 |
| EP1169082A1 (en) | 2002-01-09 |
| IL142581A0 (en) | 2002-03-10 |
| KR20010113783A (ko) | 2001-12-28 |
| HK1045270A1 (zh) | 2002-11-22 |
| AU3110300A (en) | 2000-11-14 |
| HK1043326A1 (zh) | 2002-09-13 |
| NO20014812D0 (no) | 2001-10-03 |
| RU2244573C2 (ru) | 2005-01-20 |
| PL350850A1 (en) | 2003-02-10 |
| CN1332648A (zh) | 2002-01-23 |
| TR200102816T2 (tr) | 2002-06-21 |
| JP2002541222A (ja) | 2002-12-03 |
| IL142581A (en) | 2010-12-30 |
| CN1209172C (zh) | 2005-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6738663B2 (en) | Implantable device and method for the electrical treatment of cancer | |
| US20050217682A1 (en) | Method of providing cosmetic/medical therapy | |
| JP2004504073A (ja) | 交流を用いて薬剤を送達する方法 | |
| US7742811B2 (en) | Implantable device and method for the electrical treatment of cancer | |
| KR20080080483A (ko) | 통합 코일 장치 및 이를 이용하는 방법 | |
| RU2244573C2 (ru) | Способ обеспечения косметической/медицинской терапии | |
| US5885241A (en) | Treatment with an electrically-activated substance | |
| Prajapati et al. | Lymphatic pump treatment increases thoracic duct lymph flow in conscious dogs with edema due to constriction of the inferior vena cava | |
| RU2001110081A (ru) | Способ обеспечения косметической/медицинской терапии | |
| Leeds | Cardiac resuscitation | |
| JP2002541222A5 (pt) | ||
| RU2714457C1 (ru) | Способ лечения дистрофических заболеваний позвоночника и суставов | |
| JP2700242B2 (ja) | 病気の治療装置 | |
| MXPA01010024A (en) | Method of providing cosmetic/medical therapy | |
| CA2291559A1 (en) | Alternating current prepared medicament and uses thereof | |
| US20210008102A1 (en) | Regenerative co2 treatment apparatus and method | |
| JP4217984B2 (ja) | 携帯用イオン導入器 | |
| AU752905B2 (en) | Electrically activated substance and method for making same | |
| CA2291352A1 (en) | Method of providing cosmetic/medical therapy | |
| SU1115761A1 (ru) | Способ обезболивани | |
| JPH0623060A (ja) | 電子薬物投与器 | |
| Zakzewski et al. | Effect of treatment duration on iontophoretic efficacy | |
| EA005396B1 (ru) | Способ введения лекарственных веществ в организм | |
| Ravichandran | Modelling Orthodontal Braces for Non-invasive Delivery of Anaesthetics in Dentistry | |
| Pekariã-Nað | Ðorðe M. Tešiã, Milanko Ð. Ðuriã |